1. 247PShould anthracyclines always be present in the adjuvant treatment of breast cancer (BC)? A systematic review and meta-analysis of randomized controlled trials (RCTs). (23rd October 2018) Authors: Caparica, R; Bruzzone, M; Poggio, F; Ceppi, M; de Azambuja, E; Lambertini, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 90OThe role of dose-dense (DD) adjuvant chemotherapy (CT) in HER2-positive (HER2+) early breast cancer (BC) patients (pts) before and after the introduction of trastuzumab (T): Exploratory analysis of the GIM2 trial. (13th May 2019) Authors: Lambertini, M; Bruzzone, M; Poggio, F; Conte, B; de Azambuja, E; Bisagni, G; De Laurentiis, M; de Placido, S; Cognetti, F; Del Mastro, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of pre-existing chronic kidney disease, anaemia and diabetes mellitus on mid-term mortality in patients with STEMI treated with primary PCI. (25th November 2020) Authors: Rubartelli, P; Bruzzone, M; Ariel Sanchez, F; Bologna, E; Iannone, A; Fedele, M; Bellotti, S; Bartolini, D; Boasi, V; Cannarile, P; Vercellino, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OS05.6.A Modification of the tumor microenvironment in patients with glioblastoma using autologous, genetically modified, hematopoietic stem cell-based therapy: the TEM-GBM STUDY (NCT03866109). (5th September 2022) Authors: Finocchiaro, G; Eoli, M; Gentner, B; Bruzzone, M; Di Meco, F; Mortini, P; Olivi, A; Naldini, L; Russo, C; Ciceri, F Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OS2.3 Relevance of Neurofibromatosistype 1 and schwannomotosis in extramedullary spine tumors. (6th September 2019) Authors: Eoli, M E; Bianchessi, D; Moscatelli, M; Chiapparini, L; Ibba, C; Finocchiaro, G; Bruzzone, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis. Issue 5 (27th February 2022) Authors: Arecco, L; Blondeaux, E; Bruzzone, M; Ceppi, M; Latocca, M M; Marrocco, C; Boutros, A; Spagnolo, F; Razeti, M G; Favero, D; Spinaci, S; Condorelli, M; Massarotti, C; Goldrat, O; Del Mastro, L; Demeestere, I; Lambertini, M Journal: Human reproduction Issue: Volume 37:Issue 5(2022) Page Start: 954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗